@D_AndersonID

Assistant Professor of Pharmacology at the Medical College of Georgia via Emory Healthcare and UGA College of Pharmacy

 Augusta, GA
Joined March 2019
  • Tweets46
  • Following256
  • Followers178
Daniel Anderson retweeted
Brad Spellberg@BradSpellbergApr 21
Our @wikiguidelines letter to the editor regarding the controversy between IDSA and ATS on CAP guidelines is now published. Time for societies to modernize their approach to guidelines to STOP creating care standards based on opinions. @ABsteward @DrToddLee @AnilMakam @medrants
7
35
6
109
42,256
Your Role: Review existing guidelines across all specialties to evaluate whether or not recommendations are based on high-quality, adequately powered, peer-reviewed, and publicly accessible prospective studies, including at least one randomized controlled trial
1
3
6
2,514
📢📢📢Join our team appraising the level of evidence used to make consensus guideline recommendations across all specialties Deadline to sign up: 6/20/25 New to WikiGuidelines? Use the link below to complete WikiGuidelines New Participant application. forms.office.com/r/Tyb8R0iM8…
4
5
18
5,198
Do empiric, adjunctive aminoglycosides improve outcomes in critically ill patients with GNR bloodstream infections? Not according to our propensity-matched observational cohort study!
Zoheb I. Sulaiman, DO@zsulaiman1314 May 2025
Check out our manuscript in @antibioticsmdpi #IDTwitter #MedEd 🦠💊🙏🏽 mdpi.com/2079-6382/14/5/497 @EudyJL @D_AndersonID @drdivsharma18 @MCG_AUG @mcg_id @WellstarHealth

Evaluation of Adjunctive Aminoglycoside Therapy Compared to β-Lactam Monotherapy in Critically Ill...

Background/Objectives: Gram-negative bloodstream infections (GN-BSIs) in the critically ill carry significant mortality, which is exacerbated by delays in appropriate therapy. To improve the time to...

mdpi.com
1
3
138
@AU_UGAPharmRes
1
52
Excited to present our UTI @Wiki_Guidelines in @JAMANetworkOpen. It was an honor to work with so many brilliant clinicians and an organization whose charter I so strongly believe in.
WikiGuidelines@Wiki_Guidelines4 Nov 2024
We are delighted to announce the publication of UTI WikiGuideline in JAMA Network Open. Thank you to the 54 experts from 12 countries for drafting. Special thanks to @zacroBID and @amenalor for leading the effort. jamanetwork.com/searchresult…
2
8
473
This consensus statement creates a clinical guideline for the diagnosis and management of UTIs that addresses the gap between the evidence and recommendation strength. ja.ma/3UBBW90 @bradspellberg
4
73
8
228
251,102
We are delighted to announce the publication of UTI WikiGuideline in JAMA Network Open. Thank you to the 54 experts from 12 countries for drafting. Special thanks to @zacroBID and @amenalor for leading the effort. jamanetwork.com/searchresult…
37
11
68
25,153
Congrats to @AU_UGAPharmRes former PGY1 Carly Loudermilk on her manuscript evaluating sequential PO therapy for E. Faecalis BSI. No difference in clinical outcomes and shorter hospital LOS in sequential PO. @UGAPharmacy @mcg_id @blandman19 @AndreaSikora journals.sagepub.com/doi/10.…

Evaluation of Sequential Oral Versus Intravenous Antibiotic Treatment of Enterococcus faecalis...

Background: Intravenous (IV) antibiotics have historically been considered standard of care for treatment of bloodstream infections (BSIs). Recent literature ha...

journals.sagepub.com
2
9
3
32
4,577
IV-only patients were sicker at baseline (ICU admit but not CCI or Pitt) despite matching by source of infection. Median DOT ~2 weeks in both groups. PO patients received ~7 days of IV therapy. Was the second week of therapy necessary? @EudyJL
1
3
220
Thanks to our amazing study team @strmltrofomonas @Pat_TuBROmycin @ViridansPharmD @SERGE_45_ABX and others
1
3
172
🆕️🔥The largest real-world, multicenter study of dalbavancin use for Gram-positive BSI @NicholasRebold @IDpharmresearch and many @SIDPharm 🌟s Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection #IDXposts #DOTS link.springer.com/article/10…

Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational...

Infectious Diseases and Therapy - Long-acting lipoglycopeptides such as dalbavancin may have utility in patients with Gram-positive bloodstream infections (BSI), particularly in those with barriers...

link.springer.com
3
45
3
119
25,725
Is there an exception to #ShorterIsBetter for critically ill patients with Gram-negative BSI? Not according to our propensity-matched cohort study @EudyJL @drdivsharma18 @zsulaiman13 @ABsteward @mcg_id @AU_UGAPharmRes journals.sagepub.com/doi/10.…

Evaluation of Short Versus Long Courses of Antibiotics in Critically Ill Patients With Gram-Negat...

Background: Short courses of antibiotics (7-10 days) are effective for uncomplicated gram-negative bloodstream infections (GN-BSI). However, prior studies have ...

journals.sagepub.com
2
15
1
36
6,390
Thanks to the @UGAPharmacy students who make precepting such a joy! I’m humbled and honored to be recognized by this graduating class!
UGA College of Pharmacy@UGAPharmacy5 May 2022
Congratulations to the three outstanding preceptors selected to receive this year’s Preceptor of the Year Award: - Dr. Daniel Anderson '18 - Dr. Amy Raufman Knauss '99 - Dr. Geneen Gibson Thank you for the difference you make in the lives of our students every day!
2
27
Daniel Anderson retweeted
Chris Bland@blandman191 Apr 2022
I see you @ABC_PharmD! Double Antibiotic Coverage Does Not Improve Outcomes in Febrile Neutropenia pharmacypracticenews.com/Cli…
2
5
28
Thanks to @Contagion_Live for sharing our teams work on treating ESBL UTIs!
Contagion@Contagion_Live27 Mar 2022
Both noncarbapenem β-lactams and #carbapenems produced good outcomes in #UTI from β-lactamase-producing #Enterobacterales #IDTwitter contagionlive.com/view/--lac…

β-Lactam Antibiotics Appeared Useful for UTI Despite β-Lactamase-Producing Bacteria | Contagion Live

Both noncarbapenem β-lactams and carbapenems produced good outcomes in UTI from β-lactamase-producing Enterobacterales.

contagionlive.com
1
2
Daniel Anderson retweeted
ACCP INFD PRN@accpinfdprn22 Feb 2022
🔥 NEW in OFID 🔥 👥 Retrospective cohort of admitted patients with ESBL UTI 💊 non-carbapenem beta-lactams (NCBLs) vs. carbapenems Patients receiving NCBLs experienced: ☑️ no difference in LOS ☑️ higher rates of culture clearance ☑️ shorter DOTs 🔗 academic.oup.com/ofid/articl…

Efficacy of Noncarbapenem β-Lactams Compared to Carbapenems for Extended-Spectrum β-Lactamase–Pro...

Extended-spectrum β-lactamase (ESBL)–producing organisms are commonly causative pathogens for urinary tract infections (UTIs). Carbapenems are recommended

academic.oup.com
23
82
Daniel Anderson retweeted
IDSA
@IDSAInfo22 Feb 2022
A new study in OFID suggests that carbapenems may not be necessary in the treatment of patients with urinary tract infections caused by ESBL-producing organisms. 📄: bit.ly/3JAmWA1 #IDSAJournals #OpenForumInfectDis @PaulSaxMD @DrJLi @D_AndersonID
10
78
8
252
Happy birthday to my beautiful wife! I love you @abseamon instagram.com/p/CaQ0XWtLdK97…
Congratulations🎉 to Dr. Daniel Anderson our Infectious Diseases/Internal Medicine pharmacist for his most recent publication! Way to go @D_AndersonID !! Follow the link below to read more. 🦠📰
5
31
Load more